XDx Receives $12,500,000 New Financing Round

  • Feed Type
  • Date
    1/28/2011
  • Company Name
    XDx
  • Mailing Address
    3260 Bayshore Blvd Brisbane, CA 94005
  • Company Description
    XDx is a molecular diagnostics company, XDx is one of the first companies to develop and commercialize practical applications built on insights from the Human Genome Project.
  • Website
    http://www.xdx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $12,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The financing provides the company with working capital to expand the commercialization of its FDA-cleared, innovative, non-invasive AlloMap® molecular diagnostic test and pursue the development of other gene expression-based tests for autoimmune diseases, including lupus.
  • M&A Terms
  • Venture Investor
    GE Healthare Financial Services